// App-Quantinova.ai

e14633 : Treating multiple cancers with the human anti-cancer heterologous bi-vaccine (TLNGIS).

Researchers

Presenter

  • Shuajp Kraja

Principal Investigators

  • N/A

Medical Centers

  • INB Organization, Tirana, Albania

Locations

  • Albania

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final